Furthermore, other rate-limiting enzymes, such as thymidylate synthase (TYMS), thymidine kinase 1 (TK1), and deoxythymidylate kinase (DTYMK), are upregulated in HCC and are associated with poor prognosis and cancer stemness [86,87,88]. This evidence concerns the gene TK1 and hepatocellular carcinoma.